Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 221

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

LY6E impairs coronavirus fusion and confers immune control of viral disease

Open access
Pfaender, Stephanie, Mar, Katrina B., Michailidis, Eleftherios, Kratzel, Annika, Boys, Ian N., V’kovski, Philip, Fan, Wenchun, Kelly, Jenna N., Hirt, Dagny, Ebert, Nadine, Stalder, Hanspeter, Kleine-Weber, Hannah, Hoffmann, Markus, Hoffmann, Hans-Heinrich, Saeed, Mohsan, Dijkman, Ronald, Steinmann, Eike, Wight-Carter, Mary, McDougal, Matthew B., Hanners, Natasha W., Pöhlmann, Stefan, Gallagher, Tom, Todt, Daniel, Zimmer, Gert, Rice, Charles M., Schoggins, John W., Thiel, Volker · 2020 · Nature Microbiology

Published version of a preprint

Abstract

Zoonotic coronaviruses (CoVs) are substantial threats to global health, as exemplified by the emergence of two severe acute respiratory syndrome CoVs (SARS-CoV and SARS-CoV-2) and Middle East respiratory syndrome CoV (MERS-CoV) within two decades1–3. Host immune responses to CoVs are complex and regulated in part through antiviral interferons. However, interferon-stimulated gene products that inhibit CoVs are not well characterized4. Here, we show that lymphocyte antigen 6 complex, locus E (LY6E) potently restricts infection by multiple CoVs, including SARS-CoV, SARS-CoV-2 and MERS-CoV. Mechanistic studies revealed that LY6E inhibits CoV entry into cells by interfering with spike protein-mediated membrane fusion. Importantly, mice lacking Ly6e in immune cells were highly susceptible to a murine CoV—mouse hepatitis virus. Exacerbated viral pathogenesis in Ly6e knockout mice was accompanied by loss of hepatic immune cells, higher splenic viral burden and reduction in global antiviral gene pathways. Accordingly, we found that constitutive Ly6e directly protects primary B cells from murine CoV infection. Our results show that LY6E is a critical antiviral immune effector that controls CoV infection and pathogenesis. These findings advance our understanding of immune-mediated control of CoV in vitro and in vivo—knowledge that could help inform strategies to combat infection by emerging CoVs. Here, the authors identify lymphocyte antigen 6E (LY6E) as a coronavirus (CoV) restriction factor that prevents infection of B cells and dendritic cells. LY6E inhibits both human and mouse CoV entry into cells by interfering with viral spike protein-mediated membrane fusion. It facilitates an antiviral immune response that prevents liver disease and reduces death in the mouse model of MHV-A59 CoV infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41564-020-0769-y

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 33

  1. Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020). · DOI · Paper page
  2. Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. & Fouchier, R. A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367, 1814–1820 (2012). · DOI · Paper page
  3. Kindler, E., Thiel, V. & Weber, F. Interaction of SARS and MERS coronaviruses with the antiviral interferon response. Adv. Virus Res. 96, 219–243 (2016). · DOI · Paper page
  4. Corman, V. M., Muth, D., Niemeyer, D. & Drosten, C. Hosts and sources of endemic human coronaviruses. Adv. Virus Res. 100, 163–188 (2018). · DOI · Paper page
  5. Wang, B. X. & Fish, E. N. Global virus outbreaks: interferons as 1st responders. Semin. Immunol. 43, 101300 (2019). · DOI
  6. Cervantes-Barragan, L. et al. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109, 1131–1137 (2007). · DOI · Paper page
  7. Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481–485 (2011). · DOI · Paper page
  8. Dittmann, M. et al. A serpin shapes the extracellular environment to prevent influenza A virus maturation. Cell 160, 631–643 (2015). · DOI · Paper page
  9. Mar, K. B. et al. LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step. Nat. Commun. 9, 3603 (2018). · DOI
  10. Hackett, B. A. & Cherry, S. Flavivirus internalization is regulated by a size-dependent endocytic pathway. Proc. Natl Acad. Sci. USA 115, 4246–4251 (2018). · DOI
  11. Yu, J., Liang, C. & Liu, S. L. Interferon-inducible LY6E protein promotes HIV-1 infection. J. Biol. Chem. 292, 4674–4685 (2017). · DOI
  12. Yu, J., Liang, C. & Liu, S. L. CD4-dependent modulation of HIV-1 entry by LY6E. J. Virol. 93, e01866-18 (2019). · DOI
  13. Xia, S. et al. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 30, 343–355 (2020). · DOI · Paper page
  14. Heald-Sargent, T. & Gallagher, T. Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence. Viruses 4, 557–580 (2012). · DOI · Paper page
  15. Park, J. E. et al. Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism. Proc. Natl Acad. Sci. USA 113, 12262–12267 (2016). · DOI · Paper page
  16. Kleine-Weber, H., Elzayat, M. T., Hoffmann, M. & Pohlmann, S. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein. Sci. Rep. 8, 16597 (2018). · DOI · Paper page
  17. Langford, M. B., Outhwaite, J. E., Hughes, M., Natale, D. R. C. & Simmons, D. G. Deletion of the Syncytin A receptor Ly6e impairs syncytiotrophoblast fusion and placental morphogenesis causing embryonic lethality in mice. Sci. Rep. 8, 3961 (2018). · DOI
  18. Matthews, A. E. et al. Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver. J. Immunol. 167, 5254–5263 (2001). · DOI
  19. Phares, T. W. et al. CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis. J. Virol. 86, 2416–2427 (2012). · DOI
  20. Wijburg, O. L., Heemskerk, M. H., Sanders, A., Boog, C. J. & Van Rooijen, N. Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection. Immunology 87, 34–41 (1996).
  21. Wijburg, O. L., Heemskerk, M. H., Boog, C. J. & Van Rooijen, N. Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain A59. Immunology 92, 252–258 (1997). · DOI
  22. Cervantes-Barragan, L. et al. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J. Immunol. 182, 1099–1106 (2009). · DOI
  23. Weiss, S. R. & Leibowitz, J. L. Coronavirus pathogenesis. Adv. Virus Res. 81, 85–164 (2011). · DOI · Paper page
  24. Eriksson, K. K., Cervantes-Barragan, L., Ludewig, B. & Thiel, V. Mouse hepatitis virus liver pathology is dependent on ADP-ribose-1′′-phosphatase, a viral function conserved in the alpha-like supergroup. J. Virol. 82, 12325–12334 (2008). · DOI
  25. Karnam, G. et al. CD200 receptor controls sex-specific TLR7 responses to viral infection. PLoS Pathog. 8, e1002710 (2012). · DOI
  26. Lalezari, J. P. et al. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. N. Engl. J. Med. 348, 2175–2185 (2003). · DOI · Paper page
  27. Richardson, R. B. et al. A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication. Nat. Microbiol. 3, 1214–1223 (2018). · DOI · Paper page
  28. Torriani, G. et al. Identification of clotrimazole derivatives as specific inhibitors of arenavirus fusion. J. Virol. 93, e01744-18 (2019). · DOI
  29. Gierer, S. et al. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J. Virol. 87, 5502–5511 (2013). · DOI · Paper page
  30. Hoffmann, M. et al. Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses. PLoS ONE 8, e72942 (2013). · DOI
  31. Qing, E., Hantak, M., Perlman, S. & Gallagher, T. Distinct roles for sialoside and protein receptors in coronavirus infection. mBio 11, e02764-19 (2020). · DOI
  32. Kelly, J. N. et al. Comprehensive single cell analysis of pandemic influenza A virus infection in the human airways uncovers cell-type specific host transcriptional signatures relevant for disease progression and pathogenesis. Preprint at https://doi.org/10.1101/2020.04.03.014282 (2020). · DOI
  33. V’kovski, P. et al. Disparate temperature-dependent virus–host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium. Preprint at https://doi.org/10.1101/2020.04.27.062315 (2020). · DOI

Cited by

See all 221

Metadata

Authors
Pfaender, S., Mar, K. B., Michailidis, E., Kratzel, A., Boys, I. N., V’kovski, P., Fan, W., Kelly, J. N., Hirt, D., Ebert, N., Stalder, H., Kleine-Weber, H., Hoffmann, M., Hoffmann, H.-H., Saeed, M., Dijkman, R., Steinmann, E., Wight-Carter, M., McDougal, M. B., Hanners, N. W., Pöhlmann, S., Gallagher, T., Todt, D., Zimmer, G., Rice, C. M., Schoggins, J. W., & Thiel, V.
Venue
Nature Microbiology
Published
2020-07-23
Volume
5
Issue
11
Pages
1330-1339
ISSN
2058-5276 (ISSN-L)
OpenAlex
W3044957374
Cited by
221
References
9
FWCI
4.77
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030, 173085, 310030_173085, CRSII3_160780, 179260, 166265)
  • U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI005284, AI091707, AI091707-10S1, AI132751, AI117922)
  • American Lung Association
  • Bundesministerium für Bildung und Forschung (01KI1723A, 01KI1723D)
  • National Science Foundation (2016217834, 2019274212)
  • Burroughs Wellcome Fund (‘Investigators in the Pathogenesis of Infectious Diseases’ Award)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: LY6E impairs coronavirus fusion and confers immune control of viral disease. https://app.cochat.ai/papers/10.1038/s41564-020-0769-y
The paper
Pfaender, S., Mar, K. B., Michailidis, E., Kratzel, A., Boys, I. N., V’kovski, P., Fan, W., Kelly, J. N., Hirt, D., Ebert, N., Stalder, H., Kleine-Weber, H., Hoffmann, M., Hoffmann, H.-H., Saeed, M., Dijkman, R., Steinmann, E., Wight-Carter, M., McDougal, M. B., . . . Thiel, V. (2020). LY6E impairs coronavirus fusion and confers immune control of viral disease. Nature Microbiology. https://doi.org/10.1038/s41564-020-0769-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.